Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 216 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 459 | N/A | N/A |
| Accounts receivable | N/A | N/A | -448 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 12 | N/A | N/A |
| Other Working Capital | N/A | N/A | -1,925 | N/A | N/A |
| Other Operating Activity | 225 | 1,378 | 1,338 | -3,296 | -2,204 |
| Operating Cash Flow | $225 | $1,378 | $-349 | $-3,296 | $-2,204 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -263 | -61 | -374 | -454 | -437 |
| Investing Cash Flow | $-263 | $-61 | $-374 | $-454 | $-437 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,250 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -30 | -30 | -30 |
| Financing Cash Flow | $3,250 | $N/A | $-30 | $-30 | $-30 |
| Beginning Cash Position | 9,684 | 9,684 | 11,283 | 11,366 | 11,366 |
| End Cash Position | 12,720 | 10,651 | 9,684 | 7,585 | 8,695 |
| Net Cash Flow | $3,035 | $966 | $-1,598 | $-3,780 | $-2,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | 225 | 1,378 | -349 | -3,296 | -2,204 |
| Capital Expenditure | -263 | -61 | -374 | -454 | -437 |
| Free Cash Flow | -38 | 1,318 | -723 | -3,750 | -2,641 |